Application of Radiomics in Melanoma: A Systematic Review and Meta-Analysis  Cancers. 2025;17(19)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41097659

Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trial  Breast Cancer Research and Treatment. 2025;214(1):101–112
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40759832

Association Between Dose Reduction of Cyclin-dependent Kinase 4/6 Inhibitors and Survival in Advanced Breast Cancer: A Systematic Review and Meta-analysis  Clinical Oncology (Royal College of Radiologists). 2025;48:103950
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41108947

Cancer Cachexia Rehabilitation in a Novel Outpatient Clinical Program  American Journal of Physical Medicine and Rehabilitation. 2025;104(11):1022–1027
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40856717

CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis  Frontiers in Immunology. 2025;16:1611984
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41089680

Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis  Clinical Oncology (Royal College of Radiologists). 2025;48:103943
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41101085

Effect of an herbal gel for the prevention of radiation dermatitis-related symptoms: an open-label randomized clinical trial  J Dermatolog Treat. 2025;36(1):2489595
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40229671

Effect of Co-Administration of Midazolam and Dexmedetomidine on Haemodynamics and Stress Response in Elderly Patients with Non-Small Cell Lung Cancer  Journal of Investigative Surgery. 2025;38(1):2445587
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39756799

The Effect of Exercise on Quality of Life in Patients With Advanced Lung Cancer: A Secondary Analysis of a Randomized Controlled Trial  Clinical Lung Cancer. 2025;26(7):e582–e590
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40750479

The Effect of Life Coaching on Post-Traumatic Growth and Well-Being in Breast Cancer Survivors: A Randomized Controlled Trial  Psycho-Oncology. 2025;34(10):e70295
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41068064

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial  Lancet. 2025;406(10514):1953–1968
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41052510

Impact of a nurse-led and a web-based psychoeducational program for advanced cancer patients and their caregivers: Results of a three-arm randomized controlled trial  International Journal of Nursing Studies. 2025;171:105192
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40925214

Impact of loneliness on cancer mortality: a systematic review and meta-analysis  BMJ Oncol. 2025;4(1):e000840
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41158749

Impact of pharmacist-led interventions on oncology drug therapy outcomes: a systematic review and meta-analysis  International Journal of Pharmacy Practice. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41159575

In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo  Annals of Internal Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41183346

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial  Lancet. 2025;406(10515):2078–2088
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41125109

Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China  Lancet. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41125110

Major Adverse Cardiovascular Events in Angiogenesis Inhibitor-Based Cancer Therapy: A Systematic Review and Meta-Analysis J Am Heart Assoc. 2025:e042896
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41181998

Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial  Journal of Clinical Oncology. 2025;43(31):3345–3354
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40720715

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931  Annals of Oncology. 2025;36(11):1379–1388
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40680992

Research progress of Chinese medicinal monomers in the process of melanoma occurrence  Pharmaceutical Biology. 2025;63(1):53–67
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39790031

The Role of Liquid Biopsy in the Management of Patients with Genitourinary Malignancies  European Urology. 2025;88(5):449–461
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40829964

Shared decision-making interventions in neuro-oncology practice: a systematic review  Journal of Neuro-Oncology. 2025;175(2):471–479
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549119

Tobacco Control and Smoking Cessation-Related Content in Oncology Meetings: A Systematic Scoping Review  JTO Clin Res Rep. 2025;6(11):100874
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41142140

Unveiling Enhancer RNAs in Gliomas: A Systematic Review and Qualitative Synthesis  Cancers. 2025;17(20)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41154382